Prime Medicine Announces Proposed Public Offering of Common Stock
Prime Medicine Announces Proposed Public Offering of Common Stock GlobeNewswire July 30, 2025 CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public offering of shares of its […]